FDA approves new epinephrine injector from Adamis Pharmaceuticals
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
Symjepi, the new epinephrine injector made by Adamis Pharmaceuticals Corp., is a syringe prefilled with the epinephrine hormone, which is capable of stopping life-threatening allergic reactions from insect stings, foods like eggs and certain medications.
Accordiing to San Diego-based Adamis, its new product is easier to use than EpiPen that comes filled with a set dose and is accompanied by a training device.
In addition, Symjepi will be easier to carry as it is notably smaller than EpiPen. Most kids and adults with severe allergies have to carry an injector wherever they go.
Evercore ISI analyst Umer Raffat and some others have pointed out that Symjepi isn’t totally identical to EpiPen; so its price will definitely be a key consideration.
Currently, Mylan Pharmaceuticals’ EpiPen costs in the range of $630 to $700 without insurance. The new generic version retails for around $225 to $425.
Related Articles
Interesting Updates
Popular Stories
The European Commission has confirmed that EU antitrust regulators are probing allegations of a cartel among a group of German carmakers, in an action that could result in bulky penalties for the companies.
Tesla Motors’ long-awaited Model 3 will be a “major test” for the Palo Alto-based electric car giant, according to industry analysts.
Hitting a potential milestone in the ongoing cleanup of one of the world’s worst atomic disasters, Japan has captured images of melted nuclear fuel inside the reactor 3 at the Fukushima No. 1 power plant.
Verizon Wireless has announced that it has been “optimizing” video apps on its mobile network, an admission made after several subscribers complained that their mobile data speeds were being throttled whenever they streamed videos on YouTube or Ne
The Federal Trade Commission (FTC) has confirmed that it has launched an investigation into allegations of tech giant Amazon’s misleading pricing discounts.
The U.S. Food & Drug Administration (FDA) on Thursday gave its approval for the first magnetic resonance imaging (MRI) device that can be specifically used for imaging the brains of newborn babies.
